Alumis (ALMS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Alumis (ALMS) is Moderate Underperform.

The composite score behind that read is -0.36, weighing +0.12 of bullish evidence against -0.42 bearish.

Alumis last closed at $6.77, -2.31% on the session.

Against the IVW growth benchmark the position is -2.15% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

14 graded predictions for ALMS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Alumis in the 10th percentile on return on equity, where 100 is best.

Alumis is classified under Health Care / Pharmaceuticals, with a market capitalisation of $896.98M.

StockMap tracks Alumis as the 64th largest of the 149 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 62 Moderate Underperform, 59 Neutral, 21 Strong Underperform and 7 Moderate Outperform.

On that composite Alumis ranks 103rd of 149 in the group, against a group median of -0.27.